Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation

Heart

Volumn 98, Issue 7, 2012, Pages 587-591

  Magne, Julien ^a   Mahjoub, Haifa ^b   Pierard, Luc A ^a   O'Connor, Kim ^a,b   Pirlet, Charles ^a   Pibarot, Philippe ^b   Lancellotti, Patrizio ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ADULT; AGE; ARTICLE; CARDIOVASCULAR PARAMETERS; DEGENERATIVE MITRAL REGURGITATION; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GLOBAL LONGITUDINAL STRAIN; HEART LEFT ATRIUM VOLUME; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; LEFT VENTRICLE END SYSTOLIC DIAMETER; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL DECELERATION TIME; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; PROGNOSIS; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR;

BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VENTRICULAR FUNCTION, LEFT;

EID: 84858614530     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-301128     Document Type: Article

References (36)

1. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 2007;28:230-68. (Pubitemid 46276943)
2. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148.
3. Enriquez-Sarano M, Sundt TM III. Early surgery is recommended for mitral regurgitation. Circulation 2010;121:804-11.
4. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875-83. (Pubitemid 40300296)
5. Gillam LD, Schwartz A. Primum non nocere: the case for watchful waiting in asymptomatic "severe" degenerative mitral regurgitation. Circulation 2010;121:813-21.
6. Persson A, Hartford M, Herlitz J, et al. Long-term prognostic value of mitral regurgitation in acute coronary syndromes. Heart 2010;96:1803-8.
7. Detaint D, Messika-Zeitoun D, Avierinos JF, et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 2005;111:2391-7. (Pubitemid 40647075)
8. Kerr AJ, Raffel OC, Whalley GA, et al. Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation. Eur Heart J 2008;29:363-70. (Pubitemid 351197753)
9. Pizarro R, Bazzino OO, Oberti PF, et al. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J Am Coll Cardiol 2009;54:1099-106.
10. Klaar U, Gabriel H, Bergler-Klein J, et al. Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation. Eur J Heart Fail 2011;13:163-9.
11. Pierard LA, Magne J. A new look to an old measurement. J Am Coll Cardiol 2009;54:1969-70.
12. Hetzer R, Dandel M. Early detection of left ventricular dysfunction in patients with mitral regurgitation due to flail leaflet is still a challenge. Eur Heart J 2011;32:665-7.
13. Magne J, Lancellotti P, Pierard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 2010;122:33-41.
14. Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: Mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010;11:307-32.
15. Schwammenthal E, Vered Z, Agranat O, et al. Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis: an exercise echocardiographic study. Circulation 2000;102:2378-84.
16. Magne J, Lancellotti P, Pierard LA. Exercise-induced changes in degenerative mitral regurgitation. J Am Coll Cardiol 2010;56:300-9.
17. Becker M, Hoffmann R, Kuhl HP, et al. Analysis of myocardial deformation based on ultrasonic pixel tracking to determine transmurality in chronic myocardial infarction. Eur Heart J 2006;27:2560-6. (Pubitemid 44627300)
18. Chan J, Hanekom L, Wong C, et al. Differentiation of subendocardial and transmural infarction using two-dimensional strain rate imaging to assess short-axis and longaxis myocardial function. J Am Coll Cardiol 2006;48:2026-33. (Pubitemid 44738449)
19. Lancellotti P, Cosyns B, Zacharakis D, et al. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echocardiogr 2008;21:1331-6.
20. Redfield M, Rodeheffer R, Jacobsen S, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-82. (Pubitemid 34994995)
21. Agricola E, Galderisi M, Oppizzi M, et al. Pulsed tissue Doppler imaging detects early myocardial dysfunction in asymptomatic patients with severe mitral regurgitation. Heart 2004;90:406-10. (Pubitemid 38406915)
22. Lee R, Hanekom L, Marwick TH, et al. Prediction of subclinical left ventricular dysfunction with strain rate imaging in patients with asymptomatic severe mitral regurgitation. Am J Cardiol 2004;94:1333-7. (Pubitemid 39469965)
23. Davis K, Fish L, Elahi D, et al. Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly. JAMA 1992;267:2625-9.
24. Sayama H, Nakamura Y, Saito N, et al. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron Artery Dis 1999;10:537-40. (Pubitemid 30011913)
25. Le Tourneau T, Messika-Zeitoun D, Russo A, et al. Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol 2010;56:570-8.
26. Messika-Zeitoun D, Bellamy M, Avierinos JF, et al. Left atrial remodelling in mitral regurgitationemethodologic approach, physiological determinants, and outcome implications: a prospective quantitative doppler-echocardiographic and electron beam-computed tomographic study. Eur Heart J 2007;28:1773-81. (Pubitemid 47227098)
27. Madaric J, Watripont P, Bartunek J, et al. Effect of mitral valve repair on exercise tolerance in asymptomatic patients with organic mitral regurgitation. Am Heart J 2007;154:180-5. (Pubitemid 46924805)
28. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 2006;113:2238-44.
29. Kang DH, Kim JH, Rim JH, et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation 2009;119:797-804.
30. Chenot F, Montant P, Vancraeynest D, et al. Long-term clinical outcome of mitral valve repair in asymptomatic severe mitral regurgitation. Eur J Cardiothorac Surg 2009;36:539-45.
31. Tribouilloy C, Grigioni F, Avierinos JF, et al. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol 2009;54:1961-8.
32. Barbieri A, Bursi F, Grigioni F, et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 2011;32:751-9.
33. Le Tourneau T, Richardson M, Juthier F, et al. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart 2010;96:1311-17.
34. Grigioni F, Enriquez-Sarano M, Ling L, et al. Predictors and significance of the onset of atrial fibrillation in patients with mitral regurgitation due to flail leaflets. Circulation 1999;100(Supp 1):1-520.
35. Stulak JM, Suri RM, Dearani JA, et al. Does early surgical intervention improve left ventricular mass regression after mitral valve repair for leaflet prolapse? J Thorac Cardiovasc Surg 2011;141:122-9.
36. Lee R, Haluska B, Leung DY, et al. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart 2005;91:1407-12. (Pubitemid 41531810)